Journal of Internal Medicine Concepts & Practice >
Research progress of miRNA-206 on lung diseases
ZHANG Lulu, WU Qiannan, HUO Rujie, et al . Research progress of miRNA-206 on lung diseases[J]. Journal of Internal Medicine Concepts & Practice, 2022 , 17(05) : 413 -417 . DOI: 10.16138/j.1673-6087.2022.05.014
| [1] | van Schooneveld E, Wildiers H, Vergote I, et al. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management[J]. Breast Cancer Res, 2015, 17: 21. |
| [2] | Pan Y, Liu L, Li S, et al. Activation of AMPK inhibits TGF-β1-induced airway smooth muscle cells proliferation and its potential mechanisms[J]. Sci Rep, 2018, 8(1): 3624. |
| [3] | Berindan-Neagoe I, Monroig Pdel C, Pasculli B, et al. MicroRNAome genome: a treasure for cancer diagnosis and therapy[J]. CA Cancer J Clin, 2014, 64(5): 311-336. |
| [4] | Ma G, Wang Y, Li Y, et al. MiR-206, a key modulator of skeletal muscle development and disease[J]. Int J Biol Sci, 2015, 11(3): 345-352. |
| [5] | Holgate ST, Wenzel S, Postma DS, et al. Asthma[J]. Nat Rev Dis Primers, 2015, 1(1): 15025. |
| [6] | Peebles RS Jr, Aronica MA. Proinflammatory pathways in the pathogenesis of asthma[J]. Clin Chest Med, 2019, 40(1): 29-50. |
| [7] | Park SJ, Lee YC. Interleukin-17 regulation: an attractive therapeutic approach for asthma[J]. Respir Res, 2010, 11(1): 78. |
| [8] | 钱琴芬, 熊建新, 朱琳, 等. 发作期哮喘患儿外周血单个核细胞中miR-206表达变化及意义[J]. 山东医药, 2018, 58(37): 62-64. |
| [9] | Zheng H, Zhang X, Castillo EF, et al. Leptin enhances TH2 and ILC2 responses in allergic airway disease[J]. J Biol Chem, 2016, 291(42): 22043-22052. |
| [10] | Kılıç A, Santolini M, Nakano T, et al. A systems immunology approach identifies the collective impact of 5 miRs in Th2 inflammation[J]. JCI Insight, 2018, 3(11): e97503. |
| [11] | Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?[J]. Oxid Med Cell Longev, 2016, 2016: 5698931. |
| [12] | Wang L, Xu J, Liu H, et al. PM2.5 inhibits SOD1 expression by up-regulating microRNA-206 and promotes ROS accumulation and disease progression in asthmatic mice[J]. Int Immunopharmacol, 2019, 76: 105871. |
| [13] | Hough KP, Curtiss ML, Blain TJ, et al. Airway remodeling in asthma[J]. Front Med (Lausanne), 2020, 7: 191. |
| [14] | Ojiaku CA, Yoo EJ, Panettieri RA Jr. Transforming growth factor β1 function in airway remodeling and hyperresponsiveness. the missing link?[J]. Am J Respir Cell Mol Biol, 2017, 56(4): 432-442. |
| [15] | Kistemaker LEM, Prakash YS. Airway innervation and plasticity in asthma[J]. Physiology (Bethesda), 2019, 34(4): 283-298. |
| [16] | Goodwin K, Mao S, Guyomar T, et al. Smooth muscle differentiation shapes domain branches during mouse lung development[J]. Development, 2019, 146(22): dev181172. |
| [17] | Radzikinas K, Aven L, Jiang Z, et al. A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle[J]. J Neurosci, 2011, 31(43): 15407-15415. |
| [18] | Clifford RL, Singer CA, John AE. Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function[J]. Pulm Pharmacol Ther, 2013, 26(1): 75-85. |
| [19] | Rodrigo GJ. Advances in acute asthma[J]. Curr Opin Pulm Med, 2015, 21(1): 22-26. |
| [20] | Kho AT, McGeachie MJ, Moore KG, et al. Circulating microRNAs and prediction of asthma exacerbation in childhood asthma[J]. Respir Res, 2018, 19(1): 128. |
| [21] | Lei Y, Guo W, Chen B, et al. Tumor-released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non-small cell lung cancer[J]. Oncol Rep, 2018, 40(6): 3438-3446. |
| [22] | Jiang S, Liu X, Li D, et al. Study on attenuating angiogenesis and epithelial-mesenchymal transition(EMT) of non-small cell lung carcinoma(NSCLC) by regulating MAGEC2[J]. Technol Cancer Res Treat, 2018, 17: 15330 33818797587. |
| [23] | Zhang YX, Yan YF, Liu YM, et al. Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth[J]. Cell Death Dis, 2016, 7(12): e2528. |
| [24] | Sun C, Liu Z, Li S, et al. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation[J]. Oncotarget, 2015, 6(28): 25533-25574. |
| [25] | Chen QY, Jiao DM, Wu YQ, et al. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway[J]. Oncotarget, 2016, 7(14): 18247-18261. |
| [26] | Zhang Y, Yao K, Shi C, et al. 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells[J]. Oncotarget, 2015, 6(42): 44274-44288. |
| [27] | Jiao D, Chen J, Li Y, et al. miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT[J]. J Cell Mol Med, 2018, 22(7): 3526-3536. |
| [28] | Yang Y, Wang W, Chang H, et al. Reciprocal regulation of miR-206 and IL-6/STAT3 pathway mediates IL6-induced gefitinib resistance in EGFR-mutant lung cancer cells[J]. J Cell Mol Med, 2019, 23(11): 7331-7341. |
| [29] | Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report[J]. Am J Respir Crit Care Med, 2017, 195(5): 557-582. |
| [30] | Jaitovich A, Barreiro E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2018, 198(2): 175-186. |
| [31] | Donaldson A, Natanek SA, Lewis A, et al. Increased skeletal muscle-specific microRNA in the blood of patients with COPD[J]. Thorax, 2013, 68(12): 1140-1149. |
| [32] | Carpi S, Polini B, Nieri D, et al. Expression analysis of muscle-specific miRNAs in plasma-derived extracellular vesicles from patients with chronic obstructive pulmonary disease[J]. Diagnostics (Basel), 2020, 10(7): 502. |
| [33] | Chan SMH, Selemidis S, Bozinovski S, et al. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD)[J]. Pharmacol Ther, 2019, 198: 160-188. |
| [34] | Morris HE, Neves KB, Montezano AC, et al. Notch3 signalling and vascular remodelling in pulmonary arterial hypertension[J]. Clin Sci (Lond), 2019, 133(24): 2481-2498. |
| [35] | Sun Y, An N, Li J, et al. miRNA-206 regulates human pulmonary microvascular endothelial cell apoptosis via targeting in chronic obstructive pulmonary disease[J]. J Cell Biochem, 2019, 120(4): 6223-6236. |
| [36] | Mayeux JD, Pan IZ, Dechand J, et al. Management of pulmonary arterial hypertension[J]. Curr Cardiovasc Risk Rep, 2021, 15(1): 2. |
| [37] | Lv Y, Fu L, Zhang Z, et al. Increased expression of microRNA-206 inhibits potassium voltage-gated channel subfamily a member 5 in pulmonary arterial smooth muscle cells and is related to exaggerated pulmonary artery hypertension following intrauterine growth retardation in rats[J]. J Am Heart Assoc, 2019, 8(2): e010456. |
| [38] | 白延平, 李海军, 刘智娜. miR-206在大鼠肺动脉高压模型中的表达和意义[J]. 心脏杂志, 2019, 31(6): 654-659. |
| [39] | Yue J, Guan J, Wang X, et al. MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1α/Fhl-1 pathway[J]. Lab Invest, 2013, 93(7): 748-759. |
| [40] | Jalali S, Ramanathan GK, Parthasarathy PT, et al. miR-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation[J]. PLoS One, 2012, 7(10): e46808. |
| [41] | Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia[J]. Respir Med, 2017, 132: 170-177. |
| [42] | Yen CY, Huang CY, Hou MF, et al. Evaluating the performance of fibronectin 1(FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC)[J]. Biomarkers, 2013, 18(1): 63-72. |
| [43] | Duan J, Zhang X, Zhang S, et al. miR-206 inhibits FN1 expression and proliferation and promotes apoptosis of rat type Ⅱ alveolar epithelial cells[J]. Exp Ther Med, 2017, 13(6): 3203-3208. |
| [44] | Zhang X, Xu J, Wang J, et al. Reduction of microRNA-206 contributes to the development of bronchopulmonary dysplasia through up-regulation of fibronectin 1[J]. PLoS One, 2013, 8(9): e74750. |
| [45] | Zhou J, Fu Y, Liu K, et al. miR-206 regulates alveolar type Ⅱ epithelial cell Cx43 expression in sepsis-induced acute lung injury[J]. Exp Ther Med, 2019, 18(1): 296-304. |
/
| 〈 |
|
〉 |
